DD210708A5 - Verfahren zur herstellung permanenter tierischer und humaner zellinien - Google Patents

Verfahren zur herstellung permanenter tierischer und humaner zellinien Download PDF

Info

Publication number
DD210708A5
DD210708A5 DD83250509A DD25050983A DD210708A5 DD 210708 A5 DD210708 A5 DD 210708A5 DD 83250509 A DD83250509 A DD 83250509A DD 25050983 A DD25050983 A DD 25050983A DD 210708 A5 DD210708 A5 DD 210708A5
Authority
DD
German Democratic Republic
Prior art keywords
cells
cell
fusion
human
culture
Prior art date
Application number
DD83250509A
Other languages
German (de)
English (en)
Inventor
Herbert Jungfer
Heinrich Barchet
Winfried Albert
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of DD210708A5 publication Critical patent/DD210708A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
DD83250509A 1982-05-04 1983-05-02 Verfahren zur herstellung permanenter tierischer und humaner zellinien DD210708A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3216650 1982-05-04
DE19823245665 DE3245665A1 (de) 1982-05-04 1982-12-09 Verfahren zur herstellung permanenter tierischer und humaner zellinien und deren verwendung

Publications (1)

Publication Number Publication Date
DD210708A5 true DD210708A5 (de) 1984-06-20

Family

ID=25801552

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83250509A DD210708A5 (de) 1982-05-04 1983-05-02 Verfahren zur herstellung permanenter tierischer und humaner zellinien

Country Status (18)

Country Link
US (1) US5114847A (lv)
EP (1) EP0093436B1 (lv)
JP (1) JPH0753110B2 (lv)
AU (1) AU538828B2 (lv)
CA (1) CA1201396A (lv)
DD (1) DD210708A5 (lv)
DE (2) DE3245665A1 (lv)
DK (1) DK199083A (lv)
ES (1) ES522086A0 (lv)
FI (1) FI85282C (lv)
GR (1) GR78532B (lv)
HU (1) HU196456B (lv)
IE (1) IE54881B1 (lv)
IL (1) IL68515A (lv)
LV (1) LV11042B (lv)
PT (1) PT76629B (lv)
SU (1) SU1424744A3 (lv)
YU (1) YU94883A (lv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1214123A (en) * 1983-01-20 1986-11-18 Masashi Matsui Cell lines for use in the preparation of hybridoma cells
DE3342736A1 (de) * 1983-11-25 1985-06-05 Boehringer Mannheim Gmbh, 6800 Mannheim Hybridoma-antikoerper
FR2565995B1 (fr) * 1984-03-07 1987-10-23 Centre Nat Rech Scient Cellules hybrides productrices d'un polypeptide determine et obtenu a partir de cellules primaires naturellement capables d'exprimer ce polypeptide ou un polypeptide equivalent, procede pour l'obtention de ces cellules hybrides et application de celles-ci a la production dudit polypeptide
DE3420926A1 (de) * 1984-06-05 1985-12-05 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und reagenz zur differenzierten bestimmung von isoenzymen der alkalischen phosphatase sowie hierzu geeigneter monoklonaler antikoerper
FR2581393B2 (fr) * 1985-05-02 1989-07-21 Grp Genie Genetique Cellules hybrides productrices d'un antigene caracteristique du virus de l'hepatite b obtenu a partir d'hepatocytes et de cellules etablies de singe, procede pour l'obtention de ces cellules hybrides et application de celles-ci a la production de l'antigene susdit
WO1986007379A1 (en) * 1985-06-11 1986-12-18 The Upjohn Company Transfer of male sterility in carrots
DE3525926A1 (de) 1985-07-19 1987-01-29 Boehringer Mannheim Gmbh Verfahren und reagenz zur spezifischen bestimmung von pankreas-alpha-amylase
EP0239102A3 (en) * 1986-03-28 1989-07-12 Tsuji, Kimiyoshi Process for the formation of human-human hybridoma
DE3627326A1 (de) * 1986-08-12 1988-02-18 Boehringer Mannheim Gmbh Immortalisierung durch dns-uebertragung
US5001065A (en) * 1987-05-27 1991-03-19 Cetus Corporation Human cell line and triomas, antibodies, and transformants derived therefrom
US5175004A (en) * 1988-12-27 1992-12-29 Matsumura Kenneth N Propagatable, new combinant cells for cellular replacement therapy
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5358844A (en) * 1993-02-18 1994-10-25 Brigham And Women's Hospital, Inc. Preservation of blood platelets
JP3096737B1 (ja) * 1999-07-19 2000-10-10 工業技術院長 ヒト・動物細胞培養液
WO2023069575A1 (en) * 2021-10-21 2023-04-27 Parow Entheobiosciences Llc Method for producing 5-methoxy-n,n-dimethyltryptamine (5-meo-dmt) in vitro

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1594097A (en) * 1976-12-16 1981-07-30 Int Inst Of Differentiation Production of specific immune nucleic acids cell dialysates and antibodies
US4394448A (en) * 1978-02-24 1983-07-19 Szoka Jr Francis C Method of inserting DNA into living cells
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
JPS5852634B2 (ja) * 1980-12-05 1983-11-24 株式会社林原生物化学研究所 ウロキナ−ゼの製造法
ZA824218B (en) * 1981-06-29 1983-04-27 Cetus Corp Plasmid for producing human insulin
US4465769A (en) * 1981-12-11 1984-08-14 The United States Of America As Represented By The Department Of Health And Human Services Non-transformed thymidine kinaseless cell line and its use for testing tumorigenic potential of genes
US4464465A (en) * 1982-04-05 1984-08-07 Genetic Systems Corporation Cell-driven viral transfer in eukaryotes

Also Published As

Publication number Publication date
YU94883A (en) 1988-10-31
FI85282B (fi) 1991-12-13
EP0093436B1 (de) 1986-11-05
ES8402346A1 (es) 1984-02-01
IE830945L (en) 1983-11-04
PT76629A (de) 1983-06-01
FI85282C (fi) 1992-03-25
DK199083D0 (da) 1983-05-04
IE54881B1 (en) 1990-03-14
EP0093436A2 (de) 1983-11-09
DE3245665A1 (de) 1983-11-10
CA1201396A (en) 1986-03-04
JPH0753110B2 (ja) 1995-06-07
GR78532B (lv) 1984-09-27
LV11042A (lv) 1996-02-20
FI831509L (fi) 1983-11-05
FI831509A0 (fi) 1983-05-03
HU196456B (en) 1988-11-28
ES522086A0 (es) 1984-02-01
AU1414183A (en) 1983-11-10
JPS61205486A (ja) 1986-09-11
EP0093436A3 (en) 1984-05-02
DE3367412D1 (en) 1986-12-11
DK199083A (da) 1983-11-05
IL68515A (en) 1988-11-15
PT76629B (de) 1985-12-03
SU1424744A3 (ru) 1988-09-15
US5114847A (en) 1992-05-19
LV11042B (en) 1996-06-20
AU538828B2 (en) 1984-08-30
IL68515A0 (en) 1983-07-31

Similar Documents

Publication Publication Date Title
DE3301249C2 (lv)
EP0093436B1 (de) Verfahren zur Herstellung permanenter tierischer und humaner Zellinien und deren Verwendung
JPH02227096A (ja) 抗体およびその製法
EP0980390A2 (de) Human-cd28 spezifische monoklonale antikörper zur antigenunspezifischen aktivierung von t-lymphozyten
DE4014510A1 (de) Variante cd44-oberflaechenproteine, diese kodierende c-dna-sequenzen, antikoerper gegen diese proteine sowie ihre verwendung in der diagnostik und therapie
DE3650676T2 (de) Verfahren und mittel zur sortierung und bestimmung biologischer informationen
DE3249567C2 (de) Hybridzell-Linie, Verfahren zu ihrer Herstellung und ihre Verwendung
DE10050935A1 (de) Verwendung CD28 spezifischer monoklonaler Antikörper zur Stimulation von Blutzellen, welche kein CD28 tragen
DE3687014T2 (de) Zum erkennen von tumoren faehige klonierte t-zelle und ein t-zellen-antigenrezeptor.
CH683526A5 (de) Zellinie für die Herstellung von Antikörper bildenden Hybridomen, Verfahren zur Herstellung einer menschlichen Zellinie und Antikörper produzierendes Hybridom.
DE69123121T2 (de) Synthetischer poly-ig-rezeptor, rezeptor-antikörper-komplexe, herstellung und anwendung
DE3786673T2 (de) Verfahren zur entfernung unerwünschter zellen aus menschlichen lymphozytenpopulationen, anwendung des verfahrens zur herstellung monoklonaler antikörper und dafür geeigneter kit.
AT395017B (de) Verfahren zur herstellung eines neuen lymphokins (lk 2) sowie verwendung von lk 2 zur herstellung eines pharmazeutischen praeparates
DE3239863C2 (de) Verfahren zur Herstellung eines subkultivierbaren Lymphokin-bildenden Human-T-Zell-Hybridoms
DE19647426C1 (de) Human-Coloncarcinom-Zellinien mit stabiler HSP72-Expression
DD241917A5 (de) Verwendung permanent züchtbaren menschlichen oder tierischen Zellinie
DE3627326A1 (de) Immortalisierung durch dns-uebertragung
DE68918440T2 (de) Verfahren zur transformation von menschlichen b-lymphocyten.
DE3616324C2 (de) Monoklonale Antikörper
DE19962583A1 (de) Antikörper gegen Plasmazellen
DE68913793T2 (de) Ein von einem Human-Human-Hybridom abgeleiteter monoklonaler Antikörper und dessen Verwendung.
JPS6239999B2 (lv)
DE69324375T2 (de) Herstellungsprozess von fremdprotein
EP0157271B1 (de) Hybridzell-Linie, Verfahren zu ihrer Herstellung und ihre Verwendung
EP0576862A2 (de) DNA zur Immortalisierung von humanen oder tierischen Zellen

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee